|1.||Blikslager, Anthony T: 5 articles (02/2011 - 06/2004)|
|2.||Campbell, Nigel B: 3 articles (10/2009 - 06/2007)|
|3.||Coetzee, J F: 2 articles (05/2015 - 12/2014)|
|4.||Maxwell, L K: 2 articles (02/2014 - 07/2004)|
|5.||Leslie, K E: 2 articles (05/2013 - 09/2012)|
|6.||Cook, V L: 2 articles (05/2013 - 06/2008)|
|7.||Drillich, M: 2 articles (01/2013 - 08/2007)|
|8.||Blikslager, A T: 2 articles (08/2011 - 06/2008)|
|9.||Marshall, John F: 2 articles (02/2011 - 10/2009)|
|10.||Bulbul, Aziz: 2 articles (09/2010 - 04/2010)|
01/01/2013 - "Pain management with flunixin meglumine at dehorning of calves."
04/01/2009 - "Significant differences found between treatment groups for stride length and visual assessments suggest that flunixin meglumine can be considered to provide visible pain relief up to 8 hours postcastration."
02/01/2009 - "Flunixin meglumine significantly lowered pain scores at the first postoperative recording. "
06/01/2008 - "Behavioural pain scores did not increase significantly after surgery in horses treated with flunixin meglumine. "
01/01/1996 - "One goat in the saline group required two intravenous injections of flunixin meglumine for pain."
08/04/1984 - "Treatment of five of the pneumonic calves was carried out on days 1, 2 and 3 of the trial using the anti-prostaglandin compound flunixin meglumine and that treatment appeared to be of benefit in that in the test calves there was a prompt cessation of coughing with fewer fevers and lower respiratory rates as compared with the untreated controls. "
05/01/2013 - "Flunixin meglumine was significantly more effective at ameliorating fever compared with EP. "
05/01/2009 - "Effects of flunixin meglumine on pyrexia and bioenergetic variables in postparturient dairy cows."
05/01/2002 - "One mare had a fever for 24 hours' postoperatively; this responded to a single dose of flunixin meglumine. "
01/01/2004 - "Flunixin meglumine decreased rectal temperature, whereas isoflupredone did not; however, it has not been established that reduction of fever is beneficial to cows with naturally occurring mastitis."
|3.||Body Weight (Weight, Body)
08/01/2007 - "The objective of this field trial was to evaluate effects of a single administration of 2.2 mg/kg of body weight (BW) of flunixin meglumine (FM) in addition to a systemic antibiotic treatment in cows with acute puerperal metritis (APM). "
01/04/1986 - "In a double blind trial the calves were injected intravenously with either flunixin meglumine (2 mg/kg body weight) or with a placebo. "
02/01/2014 - "Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses."
01/01/2008 - "The pharmacokinetics of flunixin meglumine was determined after its multiple (altogether 4 doses at 24-hours intervals) intravenous administration at a dose of 2.2 mg/kg body weight in six mature clinically healthy heifers. "
11/01/1999 - "Blood samples were collected at time zero (before) and 5, 10, 15, 30, and 45 minutes, and at 1, 1.25, 1.5, 1.75, 2, 2.5, 2.75, 3, 3.5, 4, 4.5, 5, 5.5, 6, and 8 hours after i.v. administration of a bolus of flunixin meglumine (1.1 mg/kg of body weight). "
07/01/1987 - "Seemingly, flunixin meglumine helped to maintain acceptable cardiovascular function and tissue perfusion during endotoxemia. "
09/01/2007 - "As result, flunixin meglumine showed depressor effect on cytokine levels in endotoxemia and the effect may be a reason for the first chosen member of nonsteroid anti-inflammatory drug in endotoxemia."
09/01/2007 - "Effect of flunixin meglumine on cytokine levels in experimental endotoxemia in mice."
01/01/1997 - "Treatments used to attempt to prevent development of endotoxemia or to treat horses with endotoxemia included i.v. fluids and administration of broad-spectrum antimicrobials and flunixin meglumine."
07/01/1988 - "Effects of flunixin meglumine in dogs following experimentally induced endotoxemia."
05/01/2013 - "The objectives of this study were to evaluate changes in weight shifting between legs while standing on a weighing platform in response to endotoxin-induced clinical mastitis, and to evaluate the effect of the nonsteroidal antiinflammatory drug flunixin meglumine on weight distribution between legs while standing in dairy cattle with endotoxin-induced clinical mastitis. "
09/01/2012 - "The use of flunixin meglumine (FM), a nonsteroidal antiinflammatory drug, during experimentally induced Escherichia coli mastitis was evaluated. "
09/01/2012 - "The effects of experimentally induced Escherichia coli mastitis and flunixin meglumine administration on activity measures, feed intake, and milk parameters."
10/01/2004 - "Field evaluation of flunixin meglumine in the supportive treatment of caprine mastitis."
12/01/2000 - "Field evaluation of flunixin meglumine in the supportive treatment of ovine mastitis."
|7.||Sodium Chloride (Saline Solution)
|9.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)